CD&R and McKesson agree to take Option Care Health private
Clayton, Dubilier & Rice and McKesson signed a definitive agreement to acquire Option Care Health for $32.05 per share in cash, implying enterprise value of approximately $5.8 billion. CD&R is set to own approximately 51%, while McKesson plans to invest approximately $1.4 billion for approximately 49%; Option Care Health would continue under its current management as a separate business. The companies expect completion during the first half of calendar year 2027 after Option Care Health stockholders vote and required regulators clear the transaction. Option Care Health shares would be removed from Nasdaq once the acquisition is completed.
Why it matters
For Option Care Health holders, the agreement offers cash consideration and would end public trading if completed. McKesson says the investment supports its strategy to broaden access to complex therapies in community-based settings; it plans to use equity-method accounting for the minority holding.
Key facts
- 1The definitive agreement sets cash consideration for Option Care Health holders at $32.05 per share. gurufocus.com
- 2The transaction has an enterprise value of approximately $5.8 billion. gurufocus.com
- 3CD&R is expected to hold approximately 51%, and McKesson plans to invest approximately $1.4 billion for approximately 49%. gurufocus.com
- 4The offer is approximately 37% above Option Care Health's October 5, 2026 closing share price. gurufocus.com
- 5Completion requires Option Care Health stockholder approval and required regulatory clearances. gurufocus.com
- 6After completion, Option Care Health common stock will no longer trade on the Nasdaq Stock Exchange. gurufocus.com
Summary written by AlphAI from 6 of 6 sources. Not investment advice. Figures are as stated by the linked sources.